Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.41 |
| ▸ | LOX | P28300 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 2/20 | 0.36 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.33 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.33 |
| ▸ | VNN1 | O95497 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19155133 | 0.82 | LOXL2 (0.38) | LOXL2LOXPPARDRXRAGRIN1 | |
| SCHEMBL1662471 | 0.79 | LOXL2 (0.49) | LOXL2LOXRXRAGRIN1GRIN2B | |
| SCHEMBL25213572 | 0.77 | PTPN7 (0.46) | LOXL2LOXPPARDSMARCA2SMARCA4 | |
| SCHEMBL25248872 | 0.74 | PSEN1 (0.50) | LOXL2LOXMGLLSMARCA2SMARCA4 | |
| SCHEMBL13603746 | 0.73 | PPARD (0.54) | PPARD | |
| SCHEMBL10200740 | 0.73 | LOXL2 (0.46) | LOXL2LOXRXRAGRIN1GRIN2B | |
| SCHEMBL1662456 | 0.72 | CCR1 (0.55) | LOXL2LOXIDO1LRRK2NOTUM | |
| SCHEMBL27894825 | 0.71 | LOXL2 (0.50) | LOXL2LOXIDO1LRRK2TGFBR1 | |
| SCHEMBL13603977 | 0.70 | MAOB (0.50) | PPARD | |
| SCHEMBL28406146 | 0.70 | LOXL2 (0.42) | LOXL2LOXRXRAGRIN1GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7638514-B2 | Agriculture | SYNGENTA CROP PROTECTION, INC. (US) | 2009-12-29 | — | — | US | disclosed |
| US-20070142229-A1 | Pesticidally active phenol derivatives | SYNGENTA CROP PROTECTION, INC. | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142229-A1 | Pesticidally active phenol derivatives | DDT, QSOX1, CHRM1 | LOXL2 1227/4885LOX 902/4885PPARD 3297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.